Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Mereo BioPharma (MREO) Gross Profit (2023 - 2025)

Historic Gross Profit for Mereo BioPharma (MREO) over the last 2 years, with Q2 2025 value amounting to $400000.0.

  • Mereo BioPharma's Gross Profit changed N/A to $400000.0 in Q2 2025 from the same period last year, while for Sep 2025 it was $400000.0, marking a year-over-year decrease of 6857.82%. This contributed to the annual value of $7.4 million for FY2023, which is 74799.3% up from last year.
  • Per Mereo BioPharma's latest filing, its Gross Profit stood at $400000.0 for Q2 2025.
  • In the past 5 years, Mereo BioPharma's Gross Profit registered a high of $5.6 million during Q2 2023, and its lowest value of -$347000.0 during Q1 2023.